Rapid In-Process Monitoring of Lentiviral Vector Particles by High-Performance Liquid Chromatography

• Main Authors: Julia Transfiguracion, Michelle Yen Tran, Stéphane Lanthier, Sonia Tremblay, Nathalie Coulombe, Mauro Acchione, Amine A. Kamen
• Format: Article
• Language: English
• Published: Elsevier 2020-09-01
• Series: Molecular Therapy: Methods & Clinical Development
• Subjects: high-performance liquid chromatography; lentiviral vector; particle quantification; Process Analytical Technologies; ratio transducing units to total particles
• Online Access: http://www.sciencedirect.com/science/article/pii/S2329050120301716

Lentiviral vectors (LVs) are a popular gene delivery tool in cell and gene therapy and they are a primary tool for ex vivo transduction of T cells for expression of chimeric antigen receptor (CAR) in CAR-T cell therapies. Extensive process and product characterization are required in manufacturing virus-based gene vectors to better control batch-to-batch variability. However, it has been an ongoing challenge to make quantitative assessments of LV product because current analytical tools often are low throughput and lack robustness and standardization is still required. This paper presents a high-throughput and robust physico-chemical characterization method that directly assesses total LV particles. With simple sample preparation and fast elution time (6.24 min) of the LV peak in 440 mM NaCl (in 20 mM Tris-HCl [pH 7.5]), this ion exchange high-performance liquid chromatography (IEX-HPLC) method is ideal for routine in-process monitoring to facilitate the development of scalable and robust LV manufacturing processes. Furthermore, this HPLC method is suitable for the analysis of all in-process samples, from crude samples such as LV supernatants to final purified products. The linearity range of the standard curve is 3.13 × 108 to 1.0 × 1010 total particles/mL, and both the intra- and inter-assay variabilities are less than 5%.